MicroRNA Profiles of Maternal and Neonatal Endothelial Progenitor Cells in Preeclampsia

• Published in: International journal of molecular sciences Vol. 22; no. 10; p. 5320
• Main Authors: Brodowski, Lars, Schröder-Heurich, Bianca, von Hardenberg, Sandra, Richter, Katja, von Kaisenberg, Constantin S., Dittrich-Breiholz, Oliver, Meyer, Nadia, Dörk, Thilo, von Versen-Höynck, Frauke
• Format: Journal Article
• Language: English
• Published: Basel MDPI AG 18.05.2021; MDPI
• Subjects: Alternative splicing; Blood; Cardiovascular disease; Cardiovascular diseases; cardiovascular morbidity; Cell culture; Cord blood; DNA methylation; Endothelial cells; endothelial progenitor cells; Epigenetics; Gene expression; hsa-miR-1270; MicroRNAs; miRNA; Morbidity; Neonates; Pre-eclampsia; Preeclampsia; Pregnancy; Progenitor cells; Splicing; Stem cells; Transcription; Transfection; Womens health
• ISSN: 1422-0067; 1661-6596; 1422-0067
• DOI: 10.3390/ijms22105320

Preeclampsia is associated with an increased cardiovascular morbidity of mother and offspring, thus contributing to a substantial burden in women and children’s health. It has been proven that endothelial progenitor cell (EPC) numbers and functional characteristics are impaired in cardiovascular disease and preeclampsia, although causative factors for the latter have remained elusive. MicroRNA (miRNA) modifications are a potential mechanism through which exposure to an altered environment translates into the development of chronic disease. In this study, we examined whether development of preeclampsia corresponds to alterations of miRNAs in maternal- and cord-blood-derived EPC. To test this end, we analyzed maternal and neonatal miRNAs via RNA sequencing from endothelial cells of preeclamptic and healthy controls in different cell culture passages. We were able to demonstrate differentially represented miRNAs in all groups. Hsa-miR-1270 showed significantly different levels in cord blood EPC from preeclampsia versus control and was negatively correlated with mRNA levels of its predicted targets ANGPTL7 and TFRC. Transfection with an hsa-miR-1270 inhibitor decreased the tube formation capacity and chemotactic motility but did not change proliferation in vitro. Target predictions and gene set enrichment analyses identified alternative splicing as a significantly enriched pathway for hsa-miR-1270. The top miRNAs in three other groups were predicted to target transcriptional and developmental pathways. Here, we showed for the first time significantly different levels of miRNAs and differently represented mRNA levels of predicted target genes in EPC derived from preeclampsia. Understanding the effects of preeclampsia on the epigenetic mechanisms of EPC will be crucial and may provide initial insights for further evaluation of the benefits of therapies targeting this cell population.